Powderly WG - Search Results

1

Effect of prolonged discontinuation of successful antiretroviral therapy on CD4+ T cell decline in human immunodeficiency virus-infected patients: implications for intermittent therapeutic strategies.

Tebas P, Henry K, Mondy K, Deeks S, Valdez H, Cohen C, Powderly WG. Tebas P, et al. Among authors: powderly wg. J Infect Dis. 2002 Sep 15;186(6):851-4. doi: 10.1086/342603. Epub 2002 Aug 28. J Infect Dis. 2002. PMID: 12198623

2

Failure of prophylactic ganciclovir to prevent cytomegalovirus disease in recipients of lung transplants.

Bailey TC, Trulock EP, Ettinger NA, Storch GA, Cooper JD, Powderly WG. Bailey TC, et al. Among authors: powderly wg. J Infect Dis. 1992 Mar;165(3):548-52. doi: 10.1093/infdis/165.3.548. J Infect Dis. 1992. PMID: 1311352 Clinical Trial.

3

Two cases of blastomycosis from a common source: use of DNA restriction analysis to identify strains.

Fraser VJ, Keath EJ, Powderly WG. Fraser VJ, et al. Among authors: powderly wg. J Infect Dis. 1991 Jun;163(6):1378-81. doi: 10.1093/infdis/163.6.1378. J Infect Dis. 1991. PMID: 1674750

4

Phase I study of atevirdine, a nonnucleoside reverse transcriptase inhibitor, in combination with zidovudine for human immunodeficiency virus type 1 infection. ACTG 199 Study Team.

Reichman RC, Morse GD, Demeter LM, Resnick L, Bassiakos Y, Fischl M, Para M, Powderly W, Leedom J, Greisberger C, et al. Reichman RC, et al. J Infect Dis. 1995 Feb;171(2):297-304. doi: 10.1093/infdis/171.2.297. J Infect Dis. 1995. PMID: 7531207 Clinical Trial.

5

Risk factors for dideoxynucleoside-induced toxic neuropathy in patients with the human immunodeficiency virus infection.

Fichtenbaum CJ, Clifford DB, Powderly WG. Fichtenbaum CJ, et al. Among authors: powderly wg. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Oct 1;10(2):169-74. doi: 10.1097/00042560-199510020-00009. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7552481

6

Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system.

Arribas JR, Clifford DB, Fichtenbaum CJ, Commins DL, Powderly WG, Storch GA. Arribas JR, et al. Among authors: powderly wg. J Infect Dis. 1995 Aug;172(2):527-31. doi: 10.1093/infdis/172.2.527. J Infect Dis. 1995. PMID: 7622897

7

Serious Pseudomonas aeruginosa infections in patients infected with human immunodeficiency virus: a case-control study.

Fichtenbaum CJ, Woeltje KF, Powderly WG. Fichtenbaum CJ, et al. Among authors: powderly wg. Clin Infect Dis. 1994 Sep;19(3):417-22. doi: 10.1093/clinids/19.3.417. Clin Infect Dis. 1994. PMID: 7811859

8

A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.

Powderly WG, Finkelstein D, Feinberg J, Frame P, He W, van der Horst C, Koletar SL, Eyster ME, Carey J, Waskin H, et al. Powderly WG, et al. N Engl J Med. 1995 Mar 16;332(11):700-5. doi: 10.1056/NEJM199503163321102. N Engl J Med. 1995. PMID: 7854376 Free article. Clinical Trial.

9

Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis.

Powderly WG, Cloud GA, Dismukes WE, Saag MS. Powderly WG, et al. Clin Infect Dis. 1994 May;18(5):789-92. doi: 10.1093/clinids/18.5.789. Clin Infect Dis. 1994. PMID: 8075272 Clinical Trial.

10

Cryptococcal meningitis and AIDS.

Powderly WG. Powderly WG. Clin Infect Dis. 1993 Nov;17(5):837-42. doi: 10.1093/clinids/17.5.837. Clin Infect Dis. 1993. PMID: 8286622 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

279 results

Search Page